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Deletion of a mycobacterial gene encoding a reductase leads to an altered cell 
wall containing β-oxo-mycolic acid analogues, and the accumulation of long-
chain ketones related to mycolic acids 
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Mycolic acids are essential components of the mycobacterial cell wall.  In this study we show 
that a gene encoding a reductase involved in the final step of mycolic acid biosynthesis can be 
deleted in Mycobacterium smegmatis without affecting cell viability.  Deletion of MSMEG4722 
(ortholog of Mycobacterium tuberculosis Rv2509) altered culture characteristics and antibiotic 
sensitivity.  The ∆MSMEG4722 strain synthesized α-alkyl, β-oxo intermediates of mycolic acids 
which were found esterified to cell wall-arabinogalactan.  While the precursors could not be 
isolated directly due to their inherent instability during base-treatment, their presence was 
established by prior reduction of the β-oxo group by sodium borohydride.  Interestingly, the 
mutant also accumulated unsaturated ketones, similar to tuberculenone from M. tuberculosis, 
which were shunt products derived from spontaneous decarboxylation of α-alkyl, β-oxo fatty 
acid precursors of mycolic acids. 
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Mycolic acids are a major and essential component of the lipid-rich cell envelope of the human 
pathogen Mycobacterium tuberculosis and other related mycobacteria.  Found either covalently 
attached to the terminal arabinose residues of the mycolyl arabinogalactan-peptidoglycan 
(mAGP) complex, or as the free glycolipids, trehalose monomycolate (TMM), trehalose 
dimycolate (TDM) and glucose monomycolate (GMM), these α-alkyl, β-hydroxyl long chain 
fatty acids play an important role in reduced cell wall permeability (Brennan and Nikaido, 1995; 
Daffe and Draper, 1998; Gao et al., 2003; Jackson et al., 1999) and virulence (Bhatt et al., 2007; 
Dubnau et al., 2000; Gao et al., 2003; Glickman et al., 2000; Rao et al., 2006) of mycobacteria.  
In M. tuberculosis, a multifunctional Type-I fatty acid synthase (FAS-I) synthesizes C16-18 and 
C24-26 fatty acids in a bimodal fashion.  The former is then channelled to a Type-II, multienzyme 
complex called fatty acid synthase II (FAS-II), which through its iterative reductive cycles 
extends the acyl chain to long chain meromycolic acids (C56-64) (Bloch, 1975, 1977; Brindley et 
al., 1969; Peterson and Bloch, 1977).  Finally, a polyketide synthase, Pks13 catalyzes the Claisen 
condensation of  a C26 fatty acid and a mero-acid to yield an α-alkyl, β-oxo acyl intermediate 
which in turn is reduced to form a mature mycolic acid (Gande et al., 2004; Portevin et al., 2004) 
(Figure 1A).  While earlier studies were focussed on identifying genes encoding ‘core’ FAS-II 
enzymes, not much was known about the final, post-Pks13 step of mycolic acid biosynthesis: the 
reduction of the β-oxo group to a hydroxyl group leading to the formation of the mycolic acid 
motif.  Unlike in mycobacteria, genes encoding enzymes involved in the biosynthesis of mycolic 
acids are non-essential in corynebacteria, facilitating the generation of null mutants.  Recently, 
Lea-Smith et al. (2007) generated a mutant of Corynebacterium glutamicum NCgl2385 that had a 
slow growth phenotype, and produced corynomycolate precursors with a β-oxo group.  In the 
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same study, the authors also used bioinformatics to identify Rv2509, the M. tuberculosis 
ortholog of NCgl2385, as a possible candidate for reduction of the mycolic acid motif (Lea-
Smith et al., 2007).  Mycobacterium smegmatis has often been used as a surrogate for M. 
tuberculosis when studying biosynthetic pathways.  The fast growing, non-pathogenic M. 
smegmatis strain is particularly useful in studying cell wall biosynthesis genes since it can 
tolerate deletion of some genes that are essential in M. tuberculosis (Amin et al., 2008; Escuyer 
et al., 2001). Moreover, while the two species differ in mero-chain modifications, core enzymes 
involved in mycolate biosynthesis are interchangeable (Brown et al., 2007; Parish et al., 2007). 
We thus chose to address the role of Rv2509 in mycobacterial mycolic acid biosynthesis by 
generating a deletion mutant of MSMEG4722, the M. smegmatis homologue of Rv2509. 
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RESULTS 
MSMEG4722 and Rv2509 encode proteins structurally similar to short chain 
reductases/dehydrogenases 
Using bioinformatics, Lea-Smith et al. (2007) identified M. tuberculosis Rv2509 as the 
homologue of NCgl2385, the C. glutamicum reductase involved in mycolic acid motif formation.  
The closest match for Rv2509 in the M. smegmatis mc2155 genome was the putative protein 
MSMEG4722 (Figure 1B).  Both predicted proteins contained conserved active site residues and 
residues for NAD/NADP binding (Figure 1B).  Predictions of the three-dimensional structures of 
proteins often give insights into potential catalytic properties. We used the @TOME server to 
screen for known structures of proteins that were predicted to be most closely related to Rv2509 
(Douguet and Labesse, 2001).  Predictions of E-values from TITO and 3D-PSSM servers (-
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121140 and 1.23e-02, respectively) strongly suggested that 1cyd (Mus musculus carbonyl 
reductase complexed with NADPH and 2-propanol) was the closest match to Rv2709 (22% 
sequence identity).  Using the 1cyd co-ordinates and the FUGUE server (Shi et al., 2001) we 
generated an in silico 3D structure of Rv2509.  The predictions revealed similar 3D structural 
folds for 1cyd, Rv2509 and the E. coli fatty acid reductase, FabG (data not shown).  
Additionally, when the NADPH moiety from 1cyd was superimposed in the predicted NADP-
binding fold of Rv2509,  the predicted distances between the conserved residues and the co-
factor showed a fit similar to that seen in 1cyd (data not shown).  These data suggested that 
Rv2509 was likely a NAD/NADP-dependent mycobacterial reductase.  As outlined above, the 
homologous M. smegmatis gene MSMEG4722 was chosen for further analysis. 
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Deletion of MSMEG4722 in M. smegmatis mc2155 alters culture characteristics and 
sensitivity to antibiotics 
To study the role of MSMEG4722 in mycolic acid motif formation, we deleted MSMEG4722 in 
M. smegmatis mc2155 by specialized transduction (Bardarov et al., 2002) (Figure 2A).  The 
ability to generate a null mutant indicated that MSMEG4722 was not essential for the viability of 
M. smegmatis mc2155.  Loss of MSMEG4722 had a remarkable effect of the colony morphology 
of M. smegmatis mc2155 on TSB agar.  While the colonies of the parental, wild type strain 
mc2155 were glossy, those of the mutant strain ∆MSMEG4722 appeared to have a dry surface 
(Figure 2B).  The change was more apparent when the strains were grown on TSB agar 
supplemented with Tween-80.  Unlike colonies of the parental strain mc2155 which had a 
smooth surface, colonies of ∆MSMEG4722 had an irregular, convoluted surface (Figure 2B).  
 5
The ∆MSMEG4722 mutant also showed a slightly slower growth rate than the parental mc2155 
strain (Figure 2C; the OD
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600 values at 24h correspond to 2×108 and 107 colony forming units/ ml 
for mc2155 and ∆MSMEG4722 respectively).  This wasn’t surprising as a similar growth defect 
was observed when the homologous gene was deleted in C. glutamicum, and a genome-wide 
transposon screen predicted that the loss of the homologous gene in M. tuberculosis would result 
in a slow growth phenotype (Lea-Smith et al., 2007; Sassetti et al., 2003).  Additionally, when 
grown in LB broth, the mutant showed an increased sensitivity to the lipophilic antibiotic 
rifampicin (MIC=0.125 µg/ml) as compared to the parental strain mc2155 (MIC=16 µg/ml), but 
not to hydrophilic antibiotics like isoniazid and ethambutol.  Wild type characteristics were 
restored on complementation of the ∆MSMEG4722 mutant with plasmid-borne MSMEG4722 
indicating that the observed phenotypes in the mutant strain were solely due to the loss of 
MSMEG4722 (Figure 2B and C). 
  
The ∆MSMEG4722 mutant failed to synthesize mature mycolic acids 
The predicted role of MSMEG4722 in mycolic acid motif formation and the observed changes in 
the colony morphology of the ∆MSMEG4722 mutant prompted us to examine mycolic acids in 
the mutant strain.  If MSMEG4722 was indeed the reductase catalyzing the conversion of the 
post Pks13, α-alkyl, β-oxo fatty acyl intermediate, then the ∆MSMEG4722 mutant would be 
expected to accumulate this unreduced intermediate of mycolic acid biosynthesis (Figure 1A).  A 
standard procedure for release of mycolic acids from mycobacteria involves base hydrolysis of 
cells using tetrabutyl ammonium hydroxide (TBAH).  This is followed by phase-transfer 
catalyzed derivatisation using methyl iodide that results in the formation of mycolic acid methyl 
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esters (MAMEs) (Dobson et al., 1985) which are analysed by TLC.  Following base-treatment 
and derivatisation, [
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14C]- labelled extracts obtained from strains were analyzed by TLC.  While 
α, α´ and epoxy MAMEs were present in the parental mc2155 strain, all three species were 
missing in the extract from the ∆MSMEG4722 strain (Figure 3A).  Instead, the mutant strain 
showed the accumulation of a product(s) with a higher retardation factor (Rf) migrating above the 
methyl esters of fatty acids (FAMEs).  When extracts from the mutant strain were analysed by 
2D-Ag+-argentation TLC, the rapidly migrating species resolved into multiple subspecies in the 
second, Ag+-containing dimension indicating the presence of multiple species differing in 
degrees of unsaturation (Figure 3B).  An identical result was obtained for extracts from 
delipidated cells which only contain cell-wall bound mycolates (Figure 3A) indicating that the 
observed changes in mycolate profiles applied to both total and specifically cell wall bound 
mycolates.  
Mycolic acid biosynthesis was restored in the mutant strain following complementation 
with not only MSMEG4722, but also Rv2509, indicating that Rv2509 was a functional 
homologue of MSMEG4722 in M. tuberculosis (strains ∆MSMEG4722-C and ∆MSMEG4722-
CRv respectively, Figure 3A). 
 
The ∆MSMEG4722 mutant accumulates precursors of mycolic acids in the cell wall 
The complete absence of α, α′ and epoxy MAMEs and appearance of new, rapidly migrating 
species in extracts of the ∆MSMEG4722 mutant suggested that these new species may either be 
precursors of mycolates or decomposition products of precursors generated as a result of the 
extraction procedure.  The latter seemed more likely as base treatment of an unreduced α-alkyl, 
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β-oxo fatty acid precursor, containing two oxo groups in close proximity has been shown to 
result in the generation of a palmitone-like decomposition product in corynebacteria (Walker et 
al., 1973).  Such decomposition products would be expected to migrate similarly to the rapidly 
migrating species that were observed in the extracts of the mutant strain.  To confirm whether 
unreduced precursors of α, α′ and epoxy mycolic acids were present in the mutant strain, cells 
were pre-treated with sodium borohydride (NaBH
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4).  This pretreatment has little effect on 
normal mycolates but results in the reduction of the β-oxo group in putative α-alkyl, β-oxo fatty 
acyl intermediates resulting in the formation of α-alkyl, β-hydroxy products, viz. mature mycolic 
acids.  Thus, if the α-alkyl, β-oxo fatty acid precursors of α, α′ and epoxy mycolic acids did 
exist in the mutant strain, pre-treatment with NaBH4 would be expected to convert these 
precursors into α, α′ and epoxy mycolic acids and TLC analysis of TBAH-treated, methylated 
extracts from NaBH4-pretreated ∆MSMEG4722 cells would show the presence of α, α′ and 
epoxy MAMEs due to the prior reduction of the β-oxo group.  When extracts of NaBH4 -
pretreated cells were analyzed by TLC, species migrating with the same Rf values as α, α´ and 
epoxy MAMEs were observed (Figure 3C).  However, additional MAMEs were also present in 
the extracts.  Two closely migrating species had a very low Rf value and were detected in total 
mycolates strains from all strains (MAME-I; Figure 3C), while another with a Rf value slightly 
greater than α-MAMEs was seen only in extracts from the mutant strain (MAME-II; Figure 3C).  
MAME-I corresponded in chromatographic migration to two hydroxylated artefacts, 
characterised previously in acid methanolysates of mycobacteria having epoxy mycolates 
(Minnikin et al., 1982).  Similar hydroxylated artefacts would be expected by NaBH4 reduction 
of the epoxy group in epoxy mycolates.  Mass spectroscopic (MS) analysis confirmed these 
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findings with molecular sizes detected in all strains corresponding to those of α, α′, epoxy 
MAMEs and to the reduced, hydroxylated products of epoxy MAMEs (Table 2).  Similar results 
were obtained when the analyses were performed on delipidated cells indicating that the α-alkyl, 
β-oxo fatty acyl precursors of mycolates from M. smegmatis were esterified to the AG in the cell 
wall (Figure 3C).  However, in this case only a single MAME-I hydroxylated component was 
produced on NaBH
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4-reduction of the delipidated cells (Figure 3C). 
The NaBH4-reduction of the β-oxo group, in a mycolate precursor, would result in two 
diastereoisomers of MAMEs which would migrate differently on TLC (Minnikin and Polgar, 
1966).  MAME-II, therefore, was likely to be a mycolate β-epimer and, on MALDI-TOF/MS, 
the molecular size was found to be identical to that of α-MAMES.  Indeed, purified MAME-II 
co-migrated with a known standard for α-MAME β-epimer (data not shown).  These results 
showed that the ∆MSMEG4722 mutant, due to loss of mycolyl reductase function, failed to make 
mature mycolic acids and instead synthesized the α-alkyl, β-oxo fatty acyl precursors of α, α´ 
and epoxy mycolates that were transported and subsequently esterified to the reducing termini of 
the AG-complex. 
 
Lipid analysis revealed accumulation of a non-polar lipid in the ∆MSMEG4722 mutant 
Polar and non-polar lipids labelled with [14C]-acetate were extracted from mc2155, 
∆MSMEG4722 and ∆MSMEG4722-C strains and analyzed by 2D-TLC (Dobson et al., 1985).  
Interestingly, the lipids corresponding to TMM and TDM in mc2155 were replaced by two lipids 
with slightly altered mobilities in the mutant strain (Figure 4A).  Both lipids had a slightly higher 
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Rf value (Rf  0.147 and Rf  0.39) than parental TMM and TDM  (Rf  0.117 and Rf  0.36) in 
direction 1.  This was likely due to esterification of the α-alkyl, β-oxo mycolic acid precursors 
rather than mature mycolic acids to trehalose in the mutant strain as was observed in the C. 
glutamicum mutant (Lea-Smith et al., 2007). Furthermore, the mutant strain showed 
accumulation of a non-polar species accompanied by a total loss of free mycolic acids (Figure 
4B, C).  This lipid species, referred to as Lipid-Y, did not stain with Dittmer-Lester reagent or 
with α-napthol-sulfuric acid indicating the absence of phosphate groups and carbohydrates (data 
not shown).  Following purification by preparative TLC, Lipid-Y was characterized by MALDI-
TOF/MS, and NMR (Figure 5).  Three species of m/z 907.6, 935.6 and 963.6 were observed in 
the mass spectra (Figure 5A) indicating a difference of m/z 28 between each species.  Further, 
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1H-NMR and 13C-NMR revealed a signal characteristic of -CH2- groups (1.3 ppm and 30 ppm, 
respectively) and indicated the presence of alkyl chains differing (CH2)2 units.  Additionally, 1H-
NMR and 13C-NMR provided evidence for the presence of cis and/or trans double bonds (1, 2, 3 
, Figure 5B-D) with latter possessing an adjacent methyl branch, (5, Figure 5B-D) and a keto 
group (14, Figure 5C-D) suggesting that Lipid-Y was a mixture of cis and trans-unsaturated long 
chain ketones (Figure 5D).  Based on the masses obtained by MALDI-TOF/MS, these 
unsaturated, branched-ketones were of chain lengths C62, C64 or C66.  Since the accumulation of 
Lipid-Y was accompanied by a loss of mycolates (and no detectable free α-alkyl, β-oxo 
mycolate precursors), it seemed likely that the ketones that comprised Lipid-Y were derived 
from free β-oxo precursors.  Free α-alkyl, β-oxo mycolate precursors could undergo 
decarboxylation to form ketones.  If this was the case, then the oxo group would be situated 
between alkyl chains that originate from a meroacid on one side and the α-branch on the other.  
Using Electron Impact-Mass Spectroscopy (EI-MS) we were able to confirm the presence of a 
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fragment of m/z 351 corresponding to the α-chain (C22) plus a carbonyl group.  In addition, the 
detection of fragments of m/z 546, 574 and 602 corresponding to C
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39, C41 and C43 mono-
unsaturated alkyl chains respectively further substantiated our findings. 
 
  
DISCUSSION 
With the exception of KasB, all enzymes involved in the biosynthesis of mycolic acids in 
mycobacterial species are encoded by essential genes (Bhatt et al., 2005; Brown et al., 2007; 
Parish et al., 2007; Portevin et al., 2004; Sacco et al., 2007).  However, we were able to generate 
a viable null mutant of MSMEG4722, the gene that encodes the reductase involved in mycolic 
acid motif synthesis in M. smegmatis.  This was not entirely surprising because global transposon 
mutagenesis screens predicted insertions in Rv2509, the M. tuberculosis homologue of 
MSMEG4722, to result in a slow growth phenotype.  Indeed, the ∆MSMEG4722 mutant did 
exhibit a slow growth rate similar to what was observed in C. glutamicum (Lea-Smith et al., 
2007). 
 Alkaline hydrolysis of the parental strain M. smegmatis mc2155 released α-, α′- and 
epoxy mycolates, as expected, but hydrolysates of the ∆MSMEG4722 mutant had no evidence 
for mycolates (Figure 3A).  Instead, hydrolysates of the mutant ∆MSMEG4722 showed the 
presence of rapidly migrating components (labelled ‘?’, Figure 3A, B). If the ∆MSMEG4722 
mutant was accumulating α-alkyl, β-oxo mycolate precursors, alkaline hydrolysis would produce 
unstable β-oxo acids, which would lose carbon dioxide to yield long-chain ketones.  Using an 
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alternative approach, we confirmed the presence of the α-alkyl, β-oxo fatty acyl precursors by 
converting them to α-alkyl, β-hydroxy fatty acids (mycolates) by prior reduction of bound 
mycolates, using NaBH
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4.  This resulted in the appearance of α, α´ and epoxy-MAMEs in 
extracts of both whole and delipidated cells from the mutant strain (Figure 3C). 
As expected (Minnikin and Polgar, 1966), reduction of the β-oxo mycolate precursors 
gave a mixture of separable diastereoisomers and the presence of the β-epimer of α-MAME was 
clearly seen (MAME-II, Figure 3C). It would be expected that the β-epimers of α′- and epoxy 
mycolates would also be produced, but such minor compounds would not be readily seen on 1D-
TLC (Figure 3C). The epoxy function is also susceptible to NaBH4 reduction and isomeric 
hydroxylated derivatives were identified (MAME-I, Figure 3C), corresponding to two artefacts 
previously characterised in acid methanolysates (Minnikin et al., 1982). However, reduction of 
the delipidated cells gave only the most polar hydroxylated derivative (Figure 3C). This strongly 
suggests that access of NaBH4 to cell wall bound epoxy mycolates was restricted. It has recently 
been shown that keto mycolates from Mycobacterium bovis BCG adopt a folded “W” 
conformation (Villeneuve et al., 2007) with the keto group in a similar hydrophilic environment 
as the hydroxy acid unit. It is reasonable to suggest that bound epoxy mycolic acids might also 
prefer such a folded “W” conformation that could direct the access of NaBH4 in a regiospecific 
manner, resulting in the formation of only a single hydroxylated derivative. It is notable that the 
covalently bound β-oxo precursors in the ∆MSMEG4722 mutant also produce only the more 
polar derivative. This would suggest that β-oxo precursors also fold in the same way as intact 
mycolates, indicating that a β-hydroxy group is not absolutely essential prerequisite for folding 
in a “W” conformation. Indeed, the fact that ∆MSMEG4722 mutant cells are viable, with β-oxo 
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mycolate analogues in their envelopes, strongly suggests that an exchange of a native β-hydroxy 
group for an unnatural β-oxo unit is permitted. However, as discussed later, the ∆MSMEG4722 
mutant cells were more permeable to lipophilic antibiotics and colony morphology was affected. 
Further studies will be needed to clarify these intriguing observations. 
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Additionally, replacement of TMM and TDM with derivatives with slightly altered TLC 
mobility in ∆MSMEG4722 (Figure 4A) suggested that the α-alkyl, β-oxo mycolate precursors 
were also esterified to trehalose.  Indeed, we obtained similar results for MAME analysis from 
extracts of whole cells (which contain wall bound and trehalose bound mycolates) as well as 
delipidated cells (which contain only wall bound mycolates) demonstrating that mycolic acids in 
both the mAGP complex and in TMM/TDM were replaced by the α-alkyl, β-oxo fatty acid 
precursors. 
 While the loss of the reductase was expected to generate precursors of mycolic acids, it 
was surprising that the α-alkyl, β-oxo fatty acids were associated with the cell wall.  These data 
suggested that mycobacterial components involved in the processing, transport and subsequent 
transfer of mycolic acids to the cell wall (including the hypothetical mycolyl transferases I and II 
and the proteins of the Antigen 85 complex; [(Takayama et al., 2005)]) were probably able to do 
the same with the α-alkyl, β-oxo fatty acid intermediates.  In contrast, Lea-Smith et al (Lea-
Smith et al., 2007) reported reduced levels of AG-mycolylation in the C. glutamicum reductase 
mutant (∆NCgl2385).  Corynomycolate derivatives released from mutant cell wall were distinct 
from wild type corynomycolates and showed a ~80% reduction in abundance.  However, the 
extraction method used in this previous study involved acid-methanolyis.  In light of our findings 
it is likely that rather than a reduction in mycolylation, the ∆NCgl2385 mutant contained equally 
 13
abundant α-alkyl, β-oxo corynomycolate precursors esterified to the AG which were not 
detected by GC and MS because of decomposition resulting from acid-methanolysis.   
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
Incorporation of the α-alkyl, β-oxo fatty acid precursors, instead of mycolic acids in the 
cell wall had a significant change in the characteristics of the cell wall of M. smegmatis 
rendering the mutant strain more susceptible to lipophilic antibiotics due to an increased 
permeability.  The presence on a β-oxo rather than a β-hydroxyl group also affected the colony 
morphology of the mutant strain, presumably due to changes in the hydrophobicity of the outer 
surface of the bacterial cells. 
A key distinction between the reductase mutants of C. glutamicum and M. smegmatis was 
the accumulation of an unusual lipid, Lipid-Y, in the latter.  MS and NMR analysis of purified 
Lipid-Y revealed it to be a mixture of unsaturated, branched ketones.  Similar ketones were 
detected in strains of Mycobacterium tuberculosis (tuberculenone) and Corynebacterium 
diptheriae (Asselineau, 1954; Pudles and Lederer, 1954).  The total number of carbons (C60±C3) 
in the mono unsaturated M. tuberculosis ketone, tuberculenone is similar to those of Lipid-Y 
(C62-C66) in the MSMEG4722 mutant.  However, tuberculenone was characterised before the 
advent of mass spectrometry (Asselineau, 1954) so precise comparisons are not meaningful. It 
has been suggested that ketones like tuberculenone are derived from decarboxylation of the α-
alkyl, β-oxo fatty acid intermediates of mycolic acids (Asselineau, 1966).  In addition to cell wall 
bound and glycolipid associated mycolates, mycobacteria also contain free mycolic acids and 
would be expected to contain some transient, unreduced mycolic acid intermediates at any given 
time.  It is likely that tuberculenone is derived from these intermediates.  In the ∆MSMEG4722 
mutant however no free mycolic acids were detected (Figure 4C).  Instead, an accumulation of 
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α-alkyl, β-oxo fatty acid intermediates would be expected to occur.  Free acids of such 
intermediates would then undergo decarboxylation to form the ketones that comprise Lipid-Y.  
Using EI-MS we were able to confirm that this was indeed the case. 
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Environmental mycobacteria are known alter cell wall mycolate composition in response 
to growth substrates resulting in a more hydrophobic wall when grown in the presence of 
hydrophobic substrates (Wick et al., 2002).  It is not clear whether mycolate reduction is 
regulated by environmental factors but our studies herein have shown that loss of the β-hydroxy 
mycolate-motif reduction alters cell wall hydrophobicity.  Whether this has an effect in vivo (in 
the case of M. tuberculosis) remains to be studied.  
In conclusion, our results clearly demonstrate that MSMEG4722 is the reductase 
involved in generation of the mycolic acid motif in M. smegmatis. The loss of this function is not 
lethal, allowing cell wall incorporation of β-oxo mycolate analogues but affecting the growth 
characteristics of the bacterium. 
 
SIGNIFICANCE 
Mycolic acid biosynthesis is essential for mycobacterial survival and many antituberculosis 
drugs like isoniazid, ethionamide and thiolactomycin target enzymes of this exclusive pathway 
(Banerjee et al., 1994; Kremer et al., 2000).  Interestingly, MSMEG4722, which catalyses the 
final step in mycolic acid biosynthesis in M. smegmatis, is non-essential and α-alkyl, β-oxo 
mycolate precursors are attached to arabinogalactan and trehalose. However, we have 
demonstrated that loss of function does cause major changes in the cell wall of M. smegmatis, 
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making it more susceptible to lipophilic antibiotics, such as rifampicin.  By extension, loss of 
Rv2509, the M. tuberculosis homologue, would be expected to have a bearing not only on 
susceptibility to antibiotics, but also on virulence as strains of M. tuberculosis with altered 
mycolic acids are highly attenuated (Bhatt et al., 2007; Dubnau et al., 2000; Glickman et al., 
2000), highlighting the potential of Rv2509 as a ‘secondary’ drug target.  Our studies also shed 
some light on the post FAS-II/Pks13 processing, transport and transfer of mycolic acids to their 
location in the cell envelope. The replacement of mycolic acids in the cell wall by the α-alkyl, β-
oxo fatty acid precursors suggested that post-Pks13 reduction of the β-oxo group was not 
necessary for the subsequent processing pathways. 
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EXPERIMENTAL PROCEDURES 
Bacterial strains, phages, plasmids and culture conditions 
All plasmids, phages and bacterial strains used in this study are shown in Table 1. Strains of 
Escherichia coli were cultured in Luria-Bertani Broth (LB; Difco).  M. smegmatis strains were 
grown in either LB broth or Tryptic Soy Broth (TSB; Difco), each containing 0.05 % Tween80.  
TSB-agar was prepared by adding 1.5 % agar to TSB prior to autoclaving.  For M. smegmatis 
hygromycin (100 µg ml-1) or kanamycin (20 µg ml-1) was used for selection while hygromycin 
(150 µg ml-1) or kanamycin (40 µg ml-1) was used for selecting recombinant E. coli strains.  
Determination of minimum inhibitory concentrations (MIC) of antibiotics was done in LB Broth 
using the Alamar Blue assay (Franzblau et al., 1998). 
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Bioinformatics 
Sequence alignments were determined using BLAST or EBI ClustalW (Chenna et al., 2003) and 
rendered using the EScript 2.2 web server. Structural predictions were performed using the 
@TOME server (Douguet and Labesse, 2001) and modeling performed using the FUGUE web 
server (http://tardis.nibio.go.jp/fugue/align.php). PyMOL (DeLano Scientific) was used to create 
POV scenes followed by rendering by POV-Ray. 
 
Construction of a MSMEG4722 null mutant 
Approximately 1-kb sequences of the upstream and downstream regions of MSMEG4722 were 
PCR amplified from M. smegmatis mc2155 genomic DNA using the primer pairs MS4722LL 
(5’-TTTTTTTTCCATAAATTGGTGGCCAGCAGGT AGTAGACG-3’) and MS4722LR (5’-
TTTTTTTTCCATTTCTTGGAGTTCGGTGGCCAACG CTTC-3’), and MS4722RL (5’-
TTTTTTTTCCATAGATTGGTGGATCGACACCGAGTAC AC-3’) and MS4722RR (5’-
TTTTTTTTCCATCTTTTGGAAACTGATCCGCTCCAAGGG-3’) respectively (all primers 
had Van91I recognition sites incorporated at the 5’ end). The PCR fragments were digested with 
Van 91I and directly cloned into Van91I digested p0004S (Gift from T. Hsu and W. R. Jacobs 
Jr., Albert Einstein College of Medicine, New York).  Recombinant plasmids obtained after 
transforming E. coli TOP-10 cells were digested with Van91I for confirmation and sequenced.  
One plasmid, p∆MSMEG4722, was linearized by PacI digestion and packaged into the 
temperature sensitive mycobacteriophage phAE159 as described (Bardarov et al., 2002) to yield 
phasmid DNA of the knockout phage ph∆MSMEG4722.  Generation of high titre phage particles 
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and specialized transduction were performed as described earlier (Bardarov et al., 2002).  Allelic 
exchange in hygromycin-resistant transductants was confirmed by Southern blot. 
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Construction of complemented strains 
MSMEG4722 was PCR amplified from M. smegmatis mc2155 genomic DNA using the primers 
MS4722-U (5'-GCAGGATCCAATGAGCCGCATGCCAGTACCCG-3') and MS4722-D (5'-
GCAGAATTCCTAACCGCCGCCGAGCTTCTTG-3') and cloned into the E. coli-
Mycobacterium shuttle plasmid pMV261 using the primer incorporated BamHI and EcoRI sites 
to yield the recombinant plasmid pMV261-MSMEG4722.  In a similar fashion, the plasmid 
pMV261-Rv2509 was constructed using Rv2509 which was PCR amplified from M. tuberculosis 
H37Rv genomic DNA using the primers Rv2509-U (5'-
GCAGGATCCAATGCCGATACCCGCGCCC-3') and Rv2509-D (5'-
GCAGAATTCCTAGCTGCCCCCAAGCCTC-3').  The complemented strains ∆MSMEG4722-
C and ∆MSMEG4722-CRv were obtained by selecting kanamycin-resistant transformants 
following electroporation of the mutant strain ∆MSMEG4722 with pMV261-MSMEG4722 or 
pMV261-Rv2509 respectively.  Electroporation was done as described earlier (Snapper et al., 
1990). 
 
Lipid and mycolic acid extraction and analysis 
Polar and apolar lipids were extracted from M. smegmatis strains and analyzed as described 
earlier (Dobson et al., 1985).  For extraction of mycolic acid methyl esters (MAMEs), both the 
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delipidated cells and the whole cell pellets were subjected to alkaline hydrolysis using 5 % 
aqueous tetrabutylammonium hydroxide (TBAH)
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 at 100°C overnight, followed by the addition 
of 4 ml of CH2Cl2, 500 µl of CH3I, 2 ml of water, followed by mixing for 30 min. The upper 
aqueous phase was discarded following centrifugation and the lower organic phase washed thrice 
with water and evaporated to dryness.  The resulting fatty acid methyl esters (FAMEs) and 
MAMEs were dissolved in diethyl ether, insoluble residues were removed by centrifugation and 
the ether solution evaporated to dryness and re-dissolved in 200 µl of CH2Cl2.  Equivalent 
volumes of the resulting solution of FAMEs and MAMEs was subjected to thin-layer 
chromatography (TLC) using silica gel plates (5735 silica gel 60F254; Merck, Darmstadt, 
Germany), developed in petroleum ether-acetone (95:5). Autoradiograms were produced by 
overnight exposure of Kodak X-Omat AR film to the plates to reveal [14C]-labelled FAMEs and 
MAMEs. Argentation-TLC was performed as above after saturation of TLC plates with 10% 
aqueous silver nitrate solution and prior activation at 100ºC for 1 h.  Lipid-Y was purified by 
preparative silica gel TLC, using petroleum ether:ethyl acetate (98:2, v/v) and detection by 
spraying with ethanolic Rhodamine 6G to visualize the lipid under a 366 nm U.V. lamp.  The 
area containing Lipid-Y was removed and extracted from the silica gel, using diethyl ether.  The 
extracted sample was then resolved on a second TLC plate in toluene:acetone (95:5, v/v) and 
purified as above.  Matrix-Assisted Laser Desorption Ionisation-Time of Flight/Mass 
Spectroscopy (MALDI-TOF/MS) of all samples was done using the Voyager DE-STR MALDI-
TOF instrument (PerSeptive Biosystems, Framingham, MA).  Nuclear Magnetic Resonance 
(NMR) spectra for Lipid-Y were recorded in CDCl3 on a Bruker DRX500 operating at 500.13 
MHz for 1H-NMR and 125.77 MHz for 13C-NMR. 
 
 19
ACKNOWLEDGEMENTS 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
The authors would like to thank T. Hsu, J. Kriakov and W. R. Jacobs Jr. (Albert Einstein College 
of Medicine, New York) for the generous gift of p0004S and phAE159, and H. Ghadbane, 
University of Birmingham for helpful comments on this manuscript.  This work was supported in 
part by a Career Development Award to A.B. from the Medical Research Council.  G.S.B. 
acknowledges support from the Wellcome Trust (Ref. 076579/Z/05/Z), the Medical Research 
Council, the Royal Society-Wolfson Research Merit Award and from Mr. James Bardrick.  
D.E.M. was a Leverhulme Emeritus Fellow (2006-2008). 
 
 
 
 
 
 
 
 
 
 
 
 20
REFERENCES 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Amin, A.G., Goude, R., Shi, L., Zhang, J., Chatterjee, D., and Parish, T. (2008). EmbA is an 
essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154, 240-248. 
Asselineau, J. (1954). Tuberculenone, an isolated insaturated ketone of the lipids of human 
strains of Mycobacterium tuberculosis. Comptes Rendus Hebdomadaires des Seances de 
l'Academie des Sciences 239, 1561-1563. 
Asselineau, J. (1966). The Bacterial Lipids (Paris: Hermann) 
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., Collins, D., 
de Lisle, G., and Jacobs, W.R., Jr. (1994). inhA, a gene encoding a target for isoniazid and 
ethionamide in Mycobacterium tuberculosis. Science 263, 227-230. 
Bardarov, S., Bardarov Jr, S., Jr., Pavelka Jr, M.S., Jr., Sambandamurthy, V., Larsen, M., 
Tufariello, J., Chan, J., Hatfull, G., and Jacobs Jr, W.R., Jr. (2002). Specialized transduction: an 
efficient method for generating marked and unmarked targeted gene disruptions in 
Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148, 3007-3017. 
Bhatt, A., Fujiwara, N., Bhatt, K., Gurcha, S.S., Kremer, L., Chen, B., Chan, J., Porcelli, S.A., 
Kobayashi, K., Besra, G.S., et al. (2007). Deletion of kasB in Mycobacterium tuberculosis causes 
loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. 
Acad. Sci. USA 104, 5157-5162. 
Bhatt, A., Kremer, L., Dai, A.Z., Sacchettini, J.C., and Jacobs, W.R., Jr. (2005). Conditional 
depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. 
J. Bacteriol. 187, 7596-7606. 
Bloch, K. (1975). Fatty acid synthases from Mycobacterium phlei. Methods Enzymol. 35, 84-90. 
Bloch, K. (1977). Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. 
Adv. Enzymol. Relat. Areas Mol. Biol. 45, 1-84. 
 21
Brennan, P.J., and Nikaido, H. (1995). The envelope of mycobacteria. Annu. Rev. Biochem. 64, 
29-63. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
Brindley, D.N., Matsumura, S., and Bloch, K. (1969). Mycobacterium phlei Fatty Acid 
Synthetase—A Bacterial Multienzyme Complex. Nature 224, 666-669. 
Brown, A.K., Bhatt, A., Singh, A., Saparia, E., Evans, A.F., and Besra, G.S. (2007). 
Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty 
acid synthase-II complex. Microbiology 153, 4166-4173. 
Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T.J., Higgins, D.G., and Thompson, 
J.D. (2003). Multiple sequence alignment with the Clustal series of programs. Nucl. Acid. Res. 
31, 3497-3500. 
Daffe, M., and Draper, P. (1998). The envelope layers of mycobacteria with reference to their 
pathogenicity. Adv. Microb. Physiol. 39, 131-203. 
Dobson, G., Minnikin, D.E., Minnikin, S.M., Parlett, M., Goodfellow, M., Ridell, M., and 
Magnusson, M. (1985). Systematic analysis of complex mycobacterial lipids. In Chemical 
Methods in Bacterial Systematics, M. Goodfellow, and D.E. Minnikin, eds. (London: Academic 
Press), pp. 237-265. 
Douguet, D., and Labesse, G. (2001). Easier threading through web-based comparisons and 
cross-validations. Bioinformatics 17, 752-753. 
Dubnau, E., Chan, J., Raynaud, C., Mohan, V.P., Laneelle, M.A., Yu, K., Quemard, A., Smith, 
I., and Daffe, M. (2000). Oxygenated mycolic acids are necessary for virulence of 
Mycobacterium tuberculosis in mice. Mol. Microbiol. 36, 630-637. 
Escuyer, V.E., Lety, M.A., Torrelles, J.B., Khoo, K.H., Tang, J.B., Rithner, C.D., Frehel, C., 
McNeil, M.R., Brennan, P.J., and Chatterjee, D. (2001). The role of the embA and embB gene 
products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium 
smegmatis arabinogalactan. J. Biol. Chem. 276, 48854-48862. 
 22
Franzblau, S.G., Witzig, R.S., McLaughlin, J.C., Torres, P., Madico, G., Hernandez, A., Degnan, 
M.T., Cook, M.B., Quenzer, V.K., Ferguson, R.M., et al. (1998). Rapid, low-technology MIC 
determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar 
Blue assay. J. Clin. Microbiol. 36, 362-366. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
Gande, R., Gibson, K.J., Brown, A.K., Krumbach, K., Dover, L.G., Sahm, H., Shioyama, S., 
Oikawa, T., Besra, G.S., and Eggeling, L. (2004). Acyl-CoA carboxylases (accD2 and accD3), 
together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in 
Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis. The 
J. Biol. Chem. 279, 44847-44857. 
Gao, L.Y., Laval, F., Lawson, E.H., Groger, R.K., Woodruff, A., Morisaki, J.H., Cox, J.S., 
Daffe, M., and Brown, E.J. (2003). Requirement for kasB in Mycobacterium mycolic acid 
biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. 
Microbiol, 49, 1547-1563. 
Glickman, M.S., Cox, J.S., and Jacobs, W.R., Jr. (2000). A novel mycolic acid cyclopropane 
synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. 
Mol. Cell 5, 717-727. 
Jackson, M., Raynaud, C., Laneelle, M.A., Guilhot, C., Laurent-Winter, C., Ensergueix, D., 
Gicquel, B., and Daffe, M. (1999). Inactivation of the antigen 85C gene profoundly affects the 
mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. 
Mol. Microbiol. 31, 1573-1587. 
Kremer, L., Douglas, J.D., Baulard, A.R., Morehouse, C., Guy, M.R., Alland, D., Dover, L.G., 
Lakey, J.H., Jacobs, W.R., Jr., Brennan, P.J., et al. (2000). Thiolactomycin and related analogues 
as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in 
Mycobacterium tuberculosis. J. Biol. Chem. 275, 16857-16864. 
Lea-Smith, D.J., Pyke, J.S., Tull, D., McConville, M.J., Coppel, R.L., and Crellin, P.K. (2007). 
The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of 
mycolic acids to arabinogalactan. J. Biol. Chem. 282, 11000-11008. 
 23
Minnikin, D.E. and Polgar, N. (1966). Stereochemical studies on the mycolic acids. Chem. 
Comm. 648-649. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Minnikin, D.E., Minnikin, S.M. and Goodfellow, M. (1982). The oxygenated mycolic acids of 
Mycobacterium fortuitum, M. farcinogenes and M. senegalense. Biochim. Biophys. Acta 712, 
616-620. 
Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffe, M., and Duncan, K. (2007). Functional 
complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium 
smegmatis fabG but not Escherichia coli fabG. J. Bacteriol. 189, 3721-3728. 
Peterson, D.O., and Bloch, K. (1977). Mycobacterium smegmatis fatty acid synthetase. Long 
chain transacylase chain length specificity. J. Biol. Chem. 252, 5735-5739. 
Portevin, D., De Sousa-D'Auria, C., Houssin, C., Grimaldi, C., Chami, M., Daffe, M., and 
Guilhot, C. (2004). A polyketide synthase catalyzes the last condensation step of mycolic acid 
biosynthesis in mycobacteria and related organisms. Proc. Natl. Acad. Sci. USA 101, 314-319. 
Pudles, J., and Lederer, E. (1954). Isolation and chemical constitution of coryno-mycolenic acid 
and of two ketones from lipids of the diphtheria bacillus. Bull. Soc. Chim. Biol. 36, 759-777. 
Rao, V., Gao, F., Chen, B., Jacobs Jr., W.R., and Glickman, M.S. (2006). Trans-
cyclopropanation of mycolic acids on trehalose dimycolate supresses Mycobacterium 
tuberculosis-induced inflammation and virulence. J. Clin. Invest. 116, 1660-1667. 
Sacco, E., Covarrubias, A.S., O'Hare, H.M., Carroll, P., Eynard, N., Jones, T.A., Parish, T., 
Daffe, M., Backbro, K., and Quemard, A. (2007). The missing piece of the type II fatty acid 
synthase system from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 104, 14628-
14633. 
Sassetti, C.M., Boyd, D.H., and Rubin, E.J. (2003). Genes required for mycobacterial growth 
defined by high density mutagenesis. Mol. Microbiol. 48, 77-84. 
 24
Shi, J., Blundell, T.L., and Mizuguchi, K. (2001). FUGUE: sequence-structure homology 
recognition using environment-specific substitution tables and structure-dependent gap penalties. 
J. Mol. Biol. 310, 243-257. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
Snapper, S.B., Melton, R.E., Mustafa, S., Kieser, T., and Jacobs, W.R., Jr. (1990). Isolation and 
characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. 
Microbiol. 4, 1911-1919. 
Stover, C.K., de la Cruz, V.F., Fuerst, T.R., Burlein, J.E., Benson, L.A., Bennett, L.T., Bansal, 
G.P., Young, J.F., Lee, M.H., Hatfull, G.F., et al. (1991). New use of BCG for recombinant 
vaccines. Nature 351, 456-460. 
Takayama, K., Wang, C., and Besra, G.S. (2005). Pathway to synthesis and processing of 
mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81-101. 
Villeneuve, M., Kawai, M., Watanabe, M., Aoyagi, Y., Hitotsuyanagi, Y., Takeya, K., Gouda, 
H., Hirono, S., Minnikin, D.E. and Nakahara, H. (2007). Conformational behavior of oxygenated 
mycobacterial mycolic acids from Mycobacterium bovis BCG. Biochim. Biophys. Acta 1768, 
1717-1726. 
Walker, R.W., Prome, J.C., and Lacave, C.S. (1973). Biosynthesis of mycolic acids. Formation 
of a C32 beta-keto ester from palmitic acid in a cell-free system of Corynebacterium diphtheriae. 
Biochim. Biophys. Acta 326, 52-62. 
Wick, L.Y., Wattiau, P., and Harms, H. (2002). Influence of the growth substrate on the mycolic 
acid profiles of mycobacteria. Environ. Microbiol. 4, 612-616. 
 
 
 
 25
FIGURE LEGENDS 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Figure 1  Mycolic acid reductases in mycobacteria 
(A)  Schematic representation of the post-FAS-II steps in mycobacterial mycolic acid 
biosynthesis.  AccD4 and AccD5 are acyl-CoA carboxylases while FadD32 is an acyl-AMP 
ligase.  It is yet unclear whether the reduction of the β-oxo group occurs while the mycolic acid 
precursor in still attached to Pks13 or after release from Pks13 by a thioesterase.  (B)  Alignment 
of amino acid sequences of Rv2509 and MSMEG4722 with 1cyd (PDB file for the structure of 
Mus musculus carbonyl reductase with NADP and 2-propanol).  α-helices and β-sheets are 
indicated above the residues as coils and arrows respectively.  Residues essential for 
NAD/NADP binding are indicated by triangles while the active site residue is indicated with a 
star.  
 
Figure 2  Generation of a MSMEG4722 null mutant 
(A)  Map of the MSMEG4722 region in the parental M. smegmatis strain mc2155 and its 
corresponding region in the ∆MSMEG4722 mutant.  res, γδ resolvase site; hyg, hygromycin 
resistance gene from Streptomyces hygroscopicus; sacB, sucrose counterselectable gene from 
Bacillus subtilis.  Digoxigenin-labelled probes were derived from ~1kb upstream and 
downstream flanking sequences that were used to construct the knockout plasmid, and are 
indicated by thick lines with square ends.  ClaI digested bands expected in a Southern blot are 
indicated in roman numerals with sizes in brackets. The inset shows the Southern blot of ClaI 
digested genomic DNA from the two strains with expected bands indicated by arrows.  (B)  
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Colonies of wild type (mc2155), mutant (∆MSMEG4722) and complemented (∆MSMEG4722-C) 
strains on TSB-agar (-) or TSB-agar + 0.05% Tween-80 (+).  Colony growth shown in upper row 
was obtained by inoculating 5µL of a broth culture on the agar plate while lower row shows 
pictures of a single isolated colony of each strain.  Scale bar =1mm.  (C)  Growth curve of wild 
type (mc
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2155), mutant (∆MSMEG4722) and complemented (∆MSMEG4722-C) strains in TSB. 
 
Figure 3  TLC analysis of mycolic acid methyl esters (MAMEs) 
(A) TLC analysis of MAMEs extracted from mc2155, ∆MSMEG4722, ∆MSMEG4722-C and 
∆MSMEG4722-CRv strains.  The rapidly migrating species observed in ∆MSMEG4722 are 
indicated by a question mark. FAMEs; fatty acid methyl esters.  (B)  2D Ag+-TLC of MAMEs 
extracted from mc2155, ∆MSMEG4722, ∆MSMEG4722-C. UFAMEs, unsaturated fatty acid 
methyl esters.  (C)  TLC analysis of MAMEs extracted from cells pre-treated with NaBH4. 
 
Figure 4  2D-TLC analysis of apolar lipids extracted from mc2155, ∆MSMEG4722 and 
∆MSMEG4722-C strains 
Panel (A), direction 1, chloroform:methanol:water, 100:14:0.8 (v/v); direction 2, 
chloroform:acetone:methanol:water, 50:60:2.5:3 (v/v).  Panel (B), direction 1, petroleum 
ether:acetone, 98:2 (v/v, thrice); direction 2, toluene:acetone, 98:2 (v/v).  Panel (C), direction 1, 
chloroform:methanol, 96:4 (v/v); direction 2, toluene:acetone, 80:20 (v/v).  TMM, trehalose 
monomycolate; TDM, trehalose dimycolate; GMM, glucose monomycolate; FA, fatty acids;  
MA, mycolic acids.   Lipid-Y is indicated by an arrow and question mark in Panel (B). 
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Figure 5  Structural analysis of  Lipid-Y 1 
2 
3 
4 
(A) MALDI-TOF/MS (B) 1H-NMR and (C) 13C-NMR of purified Lipid-Y.  Characteristic shifts 
are labelled as numbers and the structures they represent are indicated in (D). 
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Table 1 Plasmids, bacterial strains, and phages used in this study   
 
     Description Reference/source
Plasmids   
 
pMV261 E. coli-Mycobacterium shuttle plasmid 
vector with hsp60 promoter and 
KanRcassette (aph) 
(Stover et al., 1991) 
 
pMV261-MSMEG4722 
 
pMV261-Rv2509 
 
MSMEG4722 cloned in pMV261 
 
Rv2509 cloned in pMV261 
This work 
 
This work 
 
p0004s Vector for cloning allelic-exchange 
substrates to be used for specialized 
transduction; contains λ phage cos site 
and HygR cassette (hyg) 
 
Gift from T. Hsu and W.R.Jacobs Jr., 
Albert Einstein College of Medicine, 
New York 
 
p∆MSMEG4722 Derivative of p0004s designed for allelic 
exchange of M. smegmatis MSMEG4722 
This work 
Bacterial strains   
 
 
mc2155 Electroporation-proficient ept mutant of 
M. smegmatis strain mc26 
 
(Snapper et al., 1990) 
 
∆MSMEG4722  Deletion mutant of mc2155 in which 
MSMEG4722 is replaced by hyg 
This work 
 
∆MSMEG4722-C 
 
 
∆MSMEG4722-CRv 
Complemented strain of ∆MSMEG4722 
containing pMV261-MSMEG4722 
 
Complemented strain of ∆MSMEG4722 
containing pMV261-Rv2509 
 
This work 
 
 
This work 
Phages 
 
phAE159 Conditionally replicating shuttle phasmid 
derived from the lytic mycobacteriophage 
TM4 
(Bardarov et al., 2002) 
  
ph∆MSMEG4722 Derivative of phAE159 obtained by 
cloning p∆MSMEG4722 into its unique 
PacI site 
This work 
 
 
 
 
Table 2  MALDI-TOF/MS analysis of MAMEs isolated from different M. smegmatis strains.  The masses indicated are those of Na-adducts and those 
of predominant species are shown in bold.  α-epi is the isomer of α-mycolates. 
 
 
